Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
18.01
-4.73 (-20.80%)
Nov 20, 2024, 4:00 PM EST - Market closed
Upstream Bio Revenue
Upstream Bio had revenue of $607.00K in the quarter ending September 30, 2024, a decrease of -7.26%. This brings the company's revenue in the last twelve months to $2.21M. In the year 2023, Upstream Bio had annual revenue of $2.38M with 96.37% growth.
Revenue (ttm)
$2.21M
Revenue Growth
+96.37%
P/S Ratio
23.37
Revenue / Employee
$58,079
Employees
38
Market Cap
965.27M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 2.38M | 1.17M | 96.37% |
| Dec 31, 2022 | 1.21M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionUPB News
- 15 days ago - Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say - Benzinga
- 5 weeks ago - Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 5 weeks ago - Upstream Bio valued at $1.1 bln as shares jump in Nasdaq debut - Reuters
- 5 weeks ago - Upstream Bio raises $255 mln in US IPO - Reuters
- 5 weeks ago - Upstream Bio Announces Pricing of Upsized Initial Public Offering - GlobeNewsWire
- 2 months ago - Respiratory disorder biotech Upstream Bio files for a $100 million IPO - Renaissance Capital
- 2 months ago - Upstream Bio IPO Registration Document (S-1) - SEC